Stocks and Investing
Stocks and Investing
Mon, January 10, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, January 9, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, January 7, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BHVN) at Hold with Increased Target to $148 on, Jan 7th, 2022
Matthew Harrison of Morgan Stanley, Maintained "Biohaven Ltd." (BHVN) at Hold with Increased Target from $145 to $148 on, Jan 7th, 2022.
Matthew has made no other calls on BHVN in the last 4 months.
There are 5 other peers that have a rating on BHVN. Out of the 5 peers that are also analyzing BHVN, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Matthew
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $144 on, Thursday, November 18th, 2021
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $160 on, Wednesday, October 6th, 2021
- Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $170 on, Wednesday, October 6th, 2021
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $156 on, Tuesday, October 5th, 2021
- Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $165 on, Monday, September 13th, 2021
Contributing Sources